Christopher Scally

Christopher Scally is a Senior Professor at The University of Texas MD Anderson Cancer Center, specializing in surgical oncology and gastrointestinal surgery. His research focuses on soft tissue sarcoma management, including surveillance strategies for extremity sarcomas and vascular management in retroperitoneal leiomyosarcoma surgery. He investigates dedifferentiated liposarcomas treated with immune checkpoint blockade and translational comparative studies of human and canine nerve sheath tumors. His work also examines clinicopathologic and molecular characteristics of appendiceal mucinous neoplasms and outcomes of diagnostic laparoscopy in peritoneal carcinomatosis patients ineligible for HIPEC. His recent publications appear in Annals of Surgical Oncology, Current Oncology, and Frontiers in Immunology, reflecting his integration of pathology, radiation oncology, and cancer research into clinical sarcoma care.